The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Breast Cancer Statistics, 2022
Open accessAbstract
This article is the American Cancer Society’s update on female breast cancer statistics in the United States, including population‐based data on incidence, mortality, survival, and mammography screening. Breast cancer incidence rates have risen in most of the past four decades; during the most recent data years (2010–2019), the rate increased by 0.5% annually, largely driven by localized‐stage and hormone receptor‐positive disease. In contrast, breast cancer mortality rates have declined steadily since their peak in 1989, albeit at a slower pace in recent years (1.3% annually from 2011 to 2020) than in the previous decade (1.9% annually from 2002 to 2011). In total, the death rate dropped by 43% during 1989–2020, translating to 460,000 fewer breast cancer deaths during that time. The death rate declined similarly for women of all racial/ethnic groups except American Indians/Alaska Natives, among whom the rates were stable. However, despite a lower incidence rate in Black versus White women (127.8 vs. 133.7 per 100,000), the racial disparity in breast cancer mortality remained unwavering, with the death rate 40% higher in Black women overall (27.6 vs. 19.7 deaths per 100,000 in 2016–2020) and two‐fold higher among adult women younger than 50 years (12.1 vs. 6.5 deaths per 100,000). Black women have the lowest 5‐year relative survival of any racial/ethnic group for every molecular subtype and stage of disease (except stage I), with the largest Black–White gaps in absolute terms for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative disease (88% vs. 96%), hormone receptor‐negative/human epidermal growth factor receptor 2‐positive disease (78% vs. 86%), and stage III disease (64% vs. 77%). Progress against breast cancer mortality could be accelerated by mitigating racial disparities through increased access to high‐quality screening and treatment via nationwide Medicaid expansion and partnerships between community stakeholders, advocacy organizations, and health systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2022) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21708 · Cited by 17,196
Self-citationSiegel, R. L., Miller, K. D., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21442 · Cited by 16,579
Self-citationAmin, M. B., Greene, F. L., Edge, S. B., Compton, C. C., Gershenwald, J. E., Brookland, R. K., Meyer, L., Gress, D. M., Byrd, D. R., & Winchester, D. P. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21388 · Cited by 6,502
Breast Cancer Treatment: A Review
Waks, A. G., & Winer, E. P. (2019) · JAMA · doi:10.1001/jama.2018.19323 · Cited by 4,804
Cancer treatment and survivorship statistics, 2022
Miller, K. D., Nogueira, L., Devasia, T., Mariotto, A. B., Yabroff, K. R., Jemal, A., Kramer, J., & Siegel, R. L. (2022) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21731 · Cited by 3,597
Self-citationPembrolizumab for Early Triple-Negative Breast Cancer
Schmid, P., Cortes, J., Pusztai, L., McArthur, H., Kümmel, S., Bergh, J., Denkert, C., Park, Y. H., Hui, R., Harbeck, N., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1910549 · Cited by 3,270
Cancer treatment and survivorship statistics, 2012
Siegel, R., DeSantis, C., Virgo, K., Stein, K., Mariotto, A., Smith, T., Cooper, D., Gansler, T., Lerro, C., Fedewa, S., et al. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21149 · Cited by 2,928
Self-citationTrastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
Modi, S., Jacot, W., Yamashita, T., Sohn, J., Vidal, M., Tokunaga, E., Tsurutani, J., Ueno, N. T., Prat, A., Chae, Y. S., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2203690 · Cited by 2,664
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
von Minckwitz, G., Huang, C.-S., Mano, M. S., Loibl, S., Mamounas, E. P., Untch, M., Wolmark, N., Rastogi, P., Schneeweiss, A., Redondo, A., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1814017 · Cited by 2,625
Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer
Berry, D. A., Cronin, K. A., Plevritis, S. K., Fryback, D. G., Clarke, L., Zelen, M., Mandelblatt, J. S., Yakovlev, A. Y., Habbema, J. D. F., & Feuer, E. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050518 · Cited by 2,460
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
Sparano, J. A., Gray, R. J., Makower, D. F., Pritchard, K. I., Albain, K. S., Hayes, D. F., Geyer, C. E., Dees, E. C., Goetz, M. P., Olson, J. A., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1804710 · Cited by 2,397
Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement
Siu, A. L., & on behalf of the U.S. Preventive Services Task Force (2016) · Annals of Internal Medicine · doi:10.7326/m15-2886 · Cited by 2,094
Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy
Masuda, N., Lee, S.-J., Ohtani, S., Im, Y.-H., Lee, E.-S., Yokota, I., Kuroi, K., Im, S.-A., Park, B.-W., Kim, S.-B., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1612645 · Cited by 1,888
Oeffinger, K. C., Fontham, E. T. H., Etzioni, R., Herzig, A., Michaelson, J. S., Shih, Y.-C. T., Walter, L. C., Church, T. R., Flowers, C. R., LaMonte, S. J., et al. (2015) · JAMA · doi:10.1001/jama.2015.12783 · Cited by 1,653
Islami, F., Goding Sauer, A., Miller, K. D., Siegel, R. L., Fedewa, S. A., Jacobs, E. J., McCullough, M. L., Patel, A. V., Ma, J., Soerjomataram, I., et al. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21440 · Cited by 1,610
Self-citationAmerican Joint Committee on Cancer (2010) · Springer eBooks · doi:10.1007/978-0-387-88441-7 · Cited by 1,328
Hughes, K. S., Schnaper, L. A., Bellon, J. R., Cirrincione, C. T., Berry, D. A., McCormick, B., Muss, H. B., Smith, B. L., Hudis, C. A., Winer, E. P., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.2615 · Cited by 1,310
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer
Schmid, P., Cortes, J., Dent, R., Pusztai, L., McArthur, H., Kümmel, S., Bergh, J., Denkert, C., Park, Y. H., Hui, R., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2112651 · Cited by 1,274
Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer
Cortés, J., Kim, S.-B., Chung, W.-P., Im, S.-A., Park, Y. H., Hegg, R., Kim, M. H., Tseng, L.-M., Petry, V., Chung, C.-F., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2115022 · Cited by 1,175
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
Korde, L. A., Somerfield, M. R., Carey, L. A., Crews, J. R., Denduluri, N., Hwang, E. S., Khan, S. A., Loibl, S., Morris, E. A., Perez, A., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.20.03399 · Cited by 1,040
The Decrease in Breast-Cancer Incidence in 2003 in the United States
Ravdin, P. M., Cronin, K. A., Howlader, N., Berg, C. D., Chlebowski, R. T., Feuer, E. J., Edwards, B. K., & Berry, D. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmsr070105 · Cited by 982
Kohler, B. A., Sherman, R. L., Howlader, N., Jemal, A., Ryerson, A. B., Henry, K. A., Boscoe, F. P., Cronin, K. A., Lake, A., Noone, A.-M., et al. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djv048 · Cited by 915
Self-citationNationwide Trends in Mastectomy for Early-Stage Breast Cancer
Kummerow, K. L., Du, L., Penson, D. F., Shyr, Y., & Hooks, M. A. (2015) · JAMA Surgery · doi:10.1001/jamasurg.2014.2895 · Cited by 719
Iqbal, J., Ginsburg, O., Rochon, P. A., Sun, P., & Narod, S. A. (2015) · JAMA · doi:10.1001/jama.2014.17322 · Cited by 614
Cancer statistics for African American/Black People 2022
Giaquinto, A. N., Miller, K. D., Tossas, K. Y., Winn, R. A., Jemal, A., & Siegel, R. L. (2022) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21718 · Cited by 574
Self-citationAnnual Report to the Nation on the Status of Cancer, Part 1: National Cancer Statistics
Islami, F., Ward, E. M., Sung, H., Cronin, K. A., Tangka, F. K. L., Sherman, R. L., Zhao, J., Anderson, R. N., Henley, S. J., Yabroff, K. R., et al. (2021) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djab131 · Cited by 478
Self-citationSingh, G. K., & Hiatt, R. A. (2006) · International Journal of Epidemiology · doi:10.1093/ije/dyl089 · Cited by 448
Recent Advances in the Treatment of Breast Cancer
Tong, C. W. S., Wu, M., Cho, W. C. S., & To, K. K. W. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00227 · Cited by 399
Cancer statistics for the US Hispanic/Latino population, 2021
Miller, K. D., Ortiz, A. P., Pinheiro, P. S., Bandi, P., Minihan, A., Fuchs, H. E., Martinez Tyson, D., Tortolero‐Luna, G., Fedewa, S. A., Jemal, A. M., et al. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21695 · Cited by 398
Self-citationMallin, K., Browner, A., Palis, B., Gay, G., McCabe, R., Nogueira, L., Yabroff, R., Shulman, L., Facktor, M., Winchester, D. P., et al. (2019) · Annals of Surgical Oncology · doi:10.1245/s10434-019-07213-1 · Cited by 396
Effect of Screening and Adjuvant Therapy on Mortality From Breast Cancer
Berry, D. A., Cronin, K. A., Plevritis, S., Fryback, D. G., Clarke, L., Zelen, M., Mandelblatt, J. S., Yakovlev, A. Y., Habbema, J. D. F., & Feuer, E. (2006) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000201966.23445.91 · Cited by 386
Delayed Initiation of Adjuvant Chemotherapy Among Patients With Breast Cancer
Chavez-MacGregor, M., Clarke, C. A., Lichtensztajn, D. Y., & Giordano, S. H. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2015.3856 · Cited by 370
McGuire, K. P., Santillan, A. A., Kaur, P., Meade, T., Parbhoo, J., Mathias, M., Shamehdi, C., Davis, M., Ramos, D., & Cox, C. E. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0635-x · Cited by 326
Systemic Therapy for Estrogen Receptor–Positive, HER2-Negative Breast Cancer
Burstein, H. J. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1307118 · Cited by 316
Health Disparities and Triple-Negative Breast Cancer in African American Women: A Review
Newman, L. A., & Kaljee, L. M. (2017) · JAMA Surgery · doi:10.1001/jamasurg.2017.0005 · Cited by 304
Self-citationPlevritis, S. K., Munoz, D., Kurian, A. W., Stout, N. K., Alagoz, O., Near, A. M., Lee, S. J., van den Broek, J. J., Huang, X., Schechter, C. B., et al. (2018) · JAMA · doi:10.1001/jama.2017.19130 · Cited by 302
Incidence of Breast Cancer in the United States: Current and Future Trends
Anderson, W. F., Katki, H. A., & Rosenberg, P. S. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr257 · Cited by 285
Huo, D., Hu, H., Rhie, S. K., Gamazon, E. R., Cherniack, A. D., Liu, J., Yoshimatsu, T. F., Pitt, J. J., Hoadley, K. A., Troester, M., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.0595 · Cited by 283
Warner, E. T., Tamimi, R. M., Hughes, M. E., Ottesen, R. A., Wong, Y.-N., Edge, S. B., Theriault, R. L., Blayney, D. W., Niland, J. C., Winer, E. P., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.1349 · Cited by 280
American Cancer Society's report on the status of cancer disparities in the United States, 2021
Islami, F., Guerra, C. E., Minihan, A., Yabroff, K. R., Fedewa, S. A., Sloan, K., Wiedt, T. L., Thomson, B., Siegel, R. L., Nargis, N., et al. (2022) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21703 · Cited by 264
Self-citationEstimation of the Number of Individuals Living With Metastatic Cancer in the United States
Gallicchio, L., Devasia, T. P., Tonorezos, E., Mollica, M. A., & Mariotto, A. (2022) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djac158 · Cited by 210
Freedman, R. A., Virgo, K. S., He, Y., Pavluck, A. L., Winer, E. P., Ward, E. M., & Keating, N. L. (2011) · Cancer · doi:10.1002/cncr.25542 · Cited by 198
Khan, S. A., Zhao, F., Goldstein, L. J., Cella, D., Basik, M., Golshan, M., Julian, T. B., Pockaj, B. A., Lee, C. A., Razaq, W., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.02006 · Cited by 183
Jemal, A., Robbins, A. S., Lin, C. C., Flanders, W. D., DeSantis, C. E., Ward, E. M., & Freedman, R. A. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.73.7932 · Cited by 181
Self-citationPfeiffer, R. M., Webb-Vargas, Y., Wheeler, W., & Gail, M. H. (2018) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-18-0098 · Cited by 178
Giordano, S. H., Franzoi, M. A. B., Temin, S., Anders, C. K., Chandarlapaty, S., Crews, J. R., Kirshner, J. J., Krop, I. E., Lin, N. U., Morikawa, A., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.22.00519 · Cited by 176
The Emergence of the Racial Disparity in U.S. Breast-Cancer Mortality
Jatoi, I., Sung, H., & Jemal, A. (2022) · New England Journal of Medicine · doi:10.1056/nejmp2200244 · Cited by 172
Self-citationScott, L. C., Mobley, L. R., Kuo, T., & Il’yasova, D. (2019) · Cancer · doi:10.1002/cncr.32207 · Cited by 165
Collin, L. J., Gaglioti, A. H., Beyer, K. M., Zhou, Y. M., Moore, M. A., Nash, R., Switchenko, J. M., Miller‐Kleinhenz, J. M., Ward, K. C., & McCullough, L. E. (2020) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-1038 · Cited by 163
Cho, B., Han, Y., Lian, M., Colditz, G. A., Weber, J. D., Ma, C. X., & Liu, Y. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2021.1254 · Cited by 161
Breast Cancer Incidence Rates in U.S. Women Are No Longer Declining
DeSantis, C., Howlader, N., Cronin, K. A., & Jemal, A. (2011) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0061 · Cited by 159
Self-citationUpdate on mammography trends: Comparisons of rates in 2000, 2005, and 2008
Breen, N., Gentleman, J. F., & Schiller, J. S. (2011) · Cancer · doi:10.1002/cncr.25679 · Cited by 155
Albornoz, C. R., Matros, E., Lee, C. N., Hudis, C. A., Pusic, A. L., Elkin, E. B., Bach, P. B., Cordeiro, P. G., & Morrow, M. (2015) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000001276 · Cited by 150
Effects of Screening and Systemic Adjuvant Therapy on ER-Specific US Breast Cancer Mortality
Muñoz, D. F., Near, A. M., van Ravesteyn, N. T., Lee, S. J., Schechter, C. B., Alagöz, O., Berry, D. A., Burnside, E. S., Chang, Y.-J., Chisholm, G. B., et al. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju289 · Cited by 146
Rosenberg, P. S., Barker, K. A., & Anderson, W. F. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv159 · Cited by 142
Tao, L., Gomez, S. L., Keegan, T. H. M., Kurian, A. W., & Clarke, C. A. (2015) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0243 · Cited by 138
Albain, K. S., Gray, R. J., Makower, D., Faghih, A., Hayes, D. F., Geyer, C. E., Dees, E. C., Goetz, M. P., Olson, J. A., Lively, T., et al. (2020) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaa148 · Cited by 123
Pooled Analysis of Nine Cohorts Reveals Breast Cancer Risk Factors by Tumor Molecular Subtype
Gaudet, M. M., Gierach, G. L., Carter, B. D., Luo, J., Milne, R. L., Weiderpass, E., Giles, G. G., Tamimi, R. M., Eliassen, A. H., ROSNER, B. A., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0502 · Cited by 111
Emerson, M. A., Golightly, Y. M., Aiello, A. E., Reeder-Hayes, K. E., Tan, X. M., Maduekwe, U. N., Johnson‐Thompson, M., Olshan, A. F., & Troester, M. A. (2020) · Cancer · doi:10.1002/cncr.33121 · Cited by 105
Gomez, S. L., Behren, J. V., McKinley, M. A., Clarke, C. A., Shariff‐Marco, S., Cheng, I. C., Reynolds, P., & Glaser, S. L. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4229-1 · Cited by 104
Pinheiro, P. S., Morris, C. R., Liu, L., Bungum, T. J., & Altekruse, S. F. (2014) · JNCI Monographs · doi:10.1093/jncimonographs/lgu016 · Cited by 103
Miles, D. W., Ciruelos, E., Schneeweiss, A., Puglisi, F., Peretz‐Yablonski, T., Campone, M., Bondarenko, I., Nowecki, Z. I., Errihani, H. H., Paluch–Shimon, S., et al. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2021.06.024 · Cited by 103
Triple-Negative Breast Cancer: Current Practice and Future Directions
Costa, R. L. B., & Gradishar, W. J. (2017) · Journal of Oncology Practice · doi:10.1200/jop.2017.023333 · Cited by 100
Racial/Ethnic Disparities in Time to a Breast Cancer Diagnosis
Molina, Y., Silva, A., & Rauscher, G. H. (2015) · Medical Care · doi:10.1097/mlr.0000000000000417 · Cited by 92
Nash, R., Goodman, M. G., Lin, C. C., Freedman, R. A., Dominici, L. S., Ward, K. C., & Jemal, A. (2017) · JAMA Surgery · doi:10.1001/jamasurg.2017.0115 · Cited by 91
Self-citationKrieger, N., Singh, N., & Waterman, P. D. (2016) · Cancer Causes & Control · doi:10.1007/s10552-016-0793-7 · Cited by 90
Mortality Profile of the Non-Hispanic American Indian or Alaska Native Population, 2019
Arias, E., Xu, J., Curtin, S. C., Bastian, B. A., & Tejada‐Vera, B. (2021) · doi:10.15620/cdc:110370 · Cited by 84
Neighborhood Social Environmental Factors and Breast Cancer Subtypes among Black Women
Qin, B., Babel, R. A., Plascak, J. J., Lin, Y., Stroup, A. M., Goldman, N., Ambrosone, C. B., Demissie, K., Hong, C., Bandera, E. V., et al. (2020) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-1055 · Cited by 80
Linnenbringer, E. L., Geronimus, A. T., Davis, K. L., Bound, J., Ellis, L., & Gomez, S. L. (2020) · Breast Cancer Research and Treatment · doi:10.1007/s10549-020-05545-1 · Cited by 78
Taparra, K., Miller, R. C., & Deville, C. (2021) · JCO Oncology Practice · doi:10.1200/op.20.00831 · Cited by 65
Barber, L. E., Zirpoli, G., Cozier, Y. C., Rosenberg, L. A., Petrick, J. L., Bertrand, K. A., & Palmer, J. R. (2021) · Breast Cancer Research · doi:10.1186/s13058-021-01483-y · Cited by 62
Warnecke, R. B., Campbell, R. T., Vijayasiri, G., Barrett, R. E., & Rauscher, G. H. (2018) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-17-0945 · Cited by 58
The impact of changes in hormone therapy on breast cancer incidence in the US population
Coombs, N. J., Cronin, K. A., Taylor, R. J., Freedman, A. N., & Boyages, J. (2009) · Cancer Causes & Control · doi:10.1007/s10552-009-9437-5 · Cited by 54
Sung, H., DeSantis, C., Fedewa, S., Kantelhardt, E., & Jemal, A. (2019) · Cancer · doi:10.1002/cncr.32293 · Cited by 45
Self-citationLynn, B. C. D., Chernyavskiy, P., Gierach, G. L., & Rosenberg, P. S. (2021) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djab186 · Cited by 42
Receipt of locoregional therapy among young women with breast cancer
Freedman, R. A., Virgo, K. S., Labadie, J., He, Y., Partridge, A. H., & Keating, N. L. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2156-8 · Cited by 41
Trends in stage at diagnosis for young breast cancer patients in the United States
Desantis, C. E., Ma, J., & Jemal, A. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-5042-1 · Cited by 38
Self-citationMorra, A., Jung, A. Y., Behrens, S., Keeman, R., Ahearn, T. U., Anton‐Culver, H., Arndt, V., Augustinsson, A., Auvinen, P., Freeman, L. E. B., et al. (2021) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-0924 · Cited by 38
Trends in Contralateral Prophylactic Mastectomy Utilization for Small Unilateral Breast Cancer
Baskin, A. S., Wang, T., Bredbeck, B. C., Sinco, B. R., Berlin, N. L., & Dossett, L. A. (2021) · Journal of Surgical Research · doi:10.1016/j.jss.2020.12.057 · Cited by 32
Sadigh, G., Gray, R. J., Sparano, J. A., Yanez, B. R., Garcia, S. F., Timsina, L., Sledge, G. W., Cella, D. F., Wagner, L. I., & Carlos, R. C. (2021) · Cancer · doi:10.1002/cncr.33527 · Cited by 31
Palarino, J. V. (2021) · Population Research and Policy Review · doi:10.1007/s11113-021-09647-6 · Cited by 30
Differences in breast cancer outcomes amongst Black US-born and Caribbean-born immigrants
Barreto‐Coelho, P., Cerbon, D. A., Schlumbrecht, M. P., Parra, C. M., Hurley, J. E., & George, S. H. L. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-019-05403-9 · Cited by 28
Kim, G., Pastoriza, J. M., Qin, J., Lin, J., Karagiannis, G. S., Condeelis, J. S., Yothers, G., Anderson, S., Julian, T. B., Entenberg, D. R., et al. (2022) · Cancer · doi:10.1002/cncr.34241 · Cited by 26
Malinowski, C., Lei, X. J., Zhao, H., Giordano, S. H., & Chávez‐MacGregor, M. (2022) · JAMA Oncology · doi:10.1001/jamaoncol.2022.0159 · Cited by 25
Drivers of racial, regional, and socioeconomic disparities in late‐stage breast cancer mortality
Moubadder, L., Collin, L. J., Nash, R., Switchenko, J. M., Miller‐Kleinhenz, J. M., Gogineni, K., Ward, K. C., & McCullough, L. E. (2022) · Cancer · doi:10.1002/cncr.34391 · Cited by 25
Hines, L. M., Sedjo, R. L., Byers, T., John, E. M., Fejerman, L., Stern, M. C., Baumgartner, K. B., Giuliano, A. R., Torres-Mejı́a, G., Wolff, R. K., et al. (2016) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0721 · Cited by 24
The high and heterogeneous burden of breast cancer in Hawaii: A unique multiethnic U.S. Population
Loo, L. W. M., Williams, M., & Hernandez, B. Y. (2018) · Cancer Epidemiology · doi:10.1016/j.canep.2018.11.006 · Cited by 24
Sanderson, M., Pal, T., Beeghly-Fadiel, A. C., Fadden, M. K., Dujon, S.-A., Clinton, C., Jimenez, C., Davis, J. L., Fortune, M., Thompson, J., et al. (2021) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-1784 · Cited by 14
Emerging strategies for TNBC with early clinical data: new chemoimmunotherapy strategies
Hall, P. E., & Schmid, P. (2022) · Breast Cancer Research and Treatment · doi:10.1007/s10549-022-06547-x · Cited by 11
Hall, P. E., & Schmid, P. (2021) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2021.1916468 · Cited by 8
Research works printed but not linked: 11
- Centers for Disease Control and Prevention, 2019, Behavioral Risk Factor Surveillance System Survey Data 2019
- 10.1002/cncr.32472 · doi:10.1002/cncr.32472
- 10.1158/1055-9965.EPI-20-1528 · doi:10.1158/1055-9965.epi-20-1528
- Hamilton BE, 2022, Births: Provisional Data for 2021. Vital Statistics Rapid Release Report No. 20. Division of Vital Statistics, National Center for Health, Statistics
- 10.1016/j.jamcollsurg.2019.12.004 · doi:10.1016/j.jamcollsurg.2019.12.004
- 10.1002/jso.25315 · doi:10.1002/jso.25315
- 10.1001/jamasurg.2020.0322 · doi:10.1001/jamasurg.2020.0322
- 10.1016/j.semradonc.2022.01.004 · doi:10.1016/j.semradonc.2022.01.004
- 10.1245/s10434-018-6531-5 · doi:10.1245/s10434-018-6531-5
- 10.1001/jamasurg.2018.5113 · doi:10.1001/jamasurg.2018.5113
- American Cancer Society. Table 6B. Up‐to‐Date Mammography Prevalence (%) by State US 2020.Cancer Prevention & Early Detection Facts & Figures Tables and Figures 2022. American Cancer Society; 2022:32. Accessed July 1 2022.cancer.org/content/dam/cancer‐org/research/cancer‐facts‐and‐statistics/cancer‐prevention‐and‐early‐detection‐facts‐and‐figures/cped‐2022‐tables‐and‐figures.pdf
Cited by
Siegel, R. L., Miller, K. D., Wagle, N. S., & Jemal, A. (2023) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21763 · Cited by 16,303
Self-citationSiegel, R. L., Giaquinto, A. N., & Jemal, A. (2024) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21820 · Cited by 9,533
Self-citationBreast cancer: pathogenesis and treatments
Xiong, X., Zheng, L.-W., Ding, Y., Chen, Y.-F., Cai, Y.-W., Wang, L.-P., Huang, L., Liu, C.-C., Shao, Z.-M., & Yu, K.-D. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02108-4 · Cited by 958
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Wang, B., Hu, S., Teng, Y., Chen, J., Wang, H., Xu, Y., Wang, K., Xu, J., Cheng, Y., & Gao, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01889-y · Cited by 558
Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer
Ye, F., Dewanjee, S., Li, Y., Jha, N. K., Chen, Z.-S., Kumar, A., Vishakha, Behl, T., Jha, S. K., & Tang, H. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01805-y · Cited by 554
Metadata
- Authors
- Giaquinto, A. N., Sung, H., Miller, K. D., Kramer, J. L., Newman, L. A., Minihan, A., Jemal, A., & Siegel, R. L.
- Venue
- CA: A Cancer Journal for Clinicians
- Publisher
- Wiley
- Published
- 2022-10-03
- Volume
- 72
- Issue
- 6
- Pages
- 524-541
- ISSN
- 0007-9235 (ISSN-L)
- 1542-4863
- OpenAlex
- W4300690596
- Cited by
- 2,286
- References
- 90
- FWCI
- 190.87
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.